Human HLA-B27 gene enhances susceptibility of rats to oral infection by Listeria monocytogenes

American Journal of Pathology

Volumn 149, Issue 5, 1996, Pages 1737-1743

  Warner, Thomas F ^a   Madsen, Jill ^a   Starling, James ^a   Wagner, R Doug ^a   Taurog, Joel D ^b   Balish, Edward ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; GENE INDUCTION; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; IMMUNE RESPONSE; LISTERIA MONOCYTOGENES; MONONUCLEAR CELL; MOUTH INFECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; BETA 2-MICROGLOBULIN; DISEASE SUSCEPTIBILITY; HLA-B27 ANTIGEN; HUMANS; LISTERIA INFECTIONS; RATS; RATS, INBRED F344; RATS, MUTANT STRAINS; TRANSGENES;

EID: 0029904967     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Farber JM, Peterkin PI: Listeria monocytogenes, a food-borne pathogen. Microbiol Rev 1991, 55:476-511
2. Charpentier E, Gerbaud G, Jacquet C, Rocourt J, Courvalin P: Incidence of antibiotic resistance in Listeria species. J Infect Dis 1995, 172:277-281
3. Broome CV: Listeriosis: can we prevent it? ASM News 1993, 59:444-446
4. Kaufmann SHE: Immunity to intracellular bacteria. Annu Rev Immunol 1993, 11:129-163
5. 2-microglobulin-deficient mice. Infect Immun 1993, 63:1113-1116
6. Ladel CH, Flesch IA, Arnoldi J, Kaufmann SH: Studies with MHC-deficient knock-out mice reveal impact of both MHC-I- and MHC-II-dependent T cell responses on Listeria monocytogenes infection. J Immunol 1994, 153:3116-3122
7. Rakhmilevich AL: Neutrophils are essential for resolution of primary and secondary infection with Listeria monocytogenes. J Leukocyte Biol 1995, 57:827-831
8. Czuprynski CJ, Brown JF, Maroushek N, Wagner RD, Steinberg H: Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. J Immunol 1994, 152:1836-1846
9. Czuprynski CJ, Balish E: Pathogenesis of Listeria monocytogenes for gnotobiotic rats. Infect Immun 1981, 32: 323-331
10. MacDonald TT, Carter PB: Cell-mediated immunity to intestinal infection. Infect Immun 1980, 28:516-523
11. Zachar Z, Savage DC: Microbial interference and colonization of the murine gastrointestinal tract by Listeria monocytogenes. Infect Immun 1979, 23:168-174
12. Roll JT, Czuprynski C: Hemolysin is required for extraintestinal dissemination of Listeria monocytogenes in intragastrically inoculated mice. Infect Immun 1990, 58:3147-3150
13. Miller JK, Burns J: Histopathology of Listeria monocytogenes after oral feeding to mice. Appl Microbiol 1970, 19:772-775
14. Okamoto M, Nakane A, Minagawa T: Host resistance to an intragastric infection with Listeria monocytogenes in mice depends on cellular immunity and intestinal bacterial flora. Infect Immun 1994, 62:3080-3085
15. Liu Y, van Kruiningen HJ, West AB, Cartun RW, Cortot A, Colombel JF: Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology 1995, 108:1396-1404
16. 2M: an animal model of HLA-B27-associated human disorders. Cell 1990, 63:1099-1112
17. Taurog JD, Maika SD, Simmons WA, Breban M, Hammer RE: Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J Immunol 1993, 50:4168-4178
18. Hammer RE, Richardson JA, Simmons WA, White A, Breban M, Taurog JD: High prevalence of colorectal cancer in HLA-B27 transgenic F344 rats with chronic inflammatory bowel disease. J Invest Med 1995, 43: 262-268
19. Yanagisawa H, Hammer RE, Taurog JD, Richardson JA: Spontaneous immune-mediated dermatitis and alopecia in HLA-B27 transgenic rats. Am J Pathol 1995, 147:955-964
20. Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernandez-Sueiro JL, Balish E, Hammer RE: The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994, 180:2359-2364
21. Portnoy DA, Jacks PS, Hinrichs DJ: Role of hemolysin for the intracellular growth of Listeria monocytogenes. J Exp Med 1988, 167:1459-1471
22. Tilney LG, Portnoy DA: Active filaments and the growth, movement and spread of the intracellular bacterial parasite Listeria monocytogenes. J Cell Biol 1989, 109: 1597-1608
23. Taurog JD, Lipsky PE: Ankylosing spondylitis, reactive arthritis, and undifferentiated spondyloarthropathy. Harrison's Principles of Internal Medicine, ed 14. Edited by AS Fauci, E Braunwald, KJ Isselbacher, JD Wilson, JB Martin, DL Kasper, SL Hauser, DL Longo, New York, McGraw-Hill, 1996
24. Mielants H, Veys EM, Cuvelier C, Devos M, Goemaere S, Declercq L, Schatteman L, Gyselbrecht L, Elewaut D: The evolution of spondyloarthropathies in relation to gut histology: relation between gut and joint. J Rheumatol 1995, 22:2279-2284
25. Keit A: Reiter's syndrome and reactive arthritis in perspective. N Engl J Med 1983, 309:1606-1615
26. Geoffroy C, Gallard JL, Alouf J, Berche P: Purification, characterization, and toxicity of the sulfhydryl-activated hemolysin listeriolysin O from Listeria monocytogenes. Infect Immun 1987, 55:1641-1646
27. + T cells requires secretion of hemolysin and intracellular bacterial growth. J Immunol 1990, 145:3540-3546
28. Safely SA, Cluff CW, Marshall NE, Ziegler HK: Role of listeriolysin (LLO) in the T lymphocyte response to infection with Listeria monocytogenes. J Immunol 1991, 146:3604-3616
29. + T cells. Infect Immun 1995, 63:2288-2294
30. Nickerson CL, Luthra HS, Savarirayan S, David CS: Susceptibility of HLA-B27 transgenic mice to Yersinia enterocolitica infection. Hum Immunol 1990, 28: 382-396
31. Rogers HW, Unanue ER: Neutrophils are involved in acute, non-specific resistance to Listeria monocytogenes in mice. Infect Immun 1993, 61:5090-5096
32. Rosen H, Gordon S, North RJ: Exacerbation of murine listeriosis by a monoclonal antibody specific for the type 3 complement receptor of myelomonocytic cells. J Exp Med 1989, 170:27-35
33. Gough AW, Mosley RL, Stubbs CJ: Immunopathologic characterization of typhlitis and colitis in juvenile HLA-B27 transgenic rats. Pathobiology 1994, 62:221-231
34. Breban M, Hammer RE, Richardson JA, Taurog JD: Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment. J Exp Med 1993, 178:1607-1616
35. Breban M, Fernandez-Sueiro JL, Richardson JA, Hadavand RR, Maika SD, Hammer RE, Taurog JD: T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats. J Immunol 1996, 156:794-803
36. Hermann E, Yu DTY, Meyer zum Buschenfelde KH, Fleischer B: HLA-B27-restricted CD8 T-cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 1993, 342:646-650
37. Simmons WA, Leong LYW, Satumtira N, Butcher GA, Howard JC, Slaughter CA, Richardson JA, Hammer RE, Taurog JD: Rat MHC-linked peptide transporter alleles strongly influence peptide binding by HLA-B27 but not B27-associated inflammatory disease. J Immunol 1996, 156:1661-1667
38. Kapasi K, Inman RD: MEI epitope of HLA-B27 confers class I-mediated modulation of gram-negative bacterial invasion. J Immunol 1994, 153:833-840